Topic
Biomarkers
21 Podcasts • 1 Case • 2 Courses on BackTable
Episode # 314 • 07 Jul 2026
Exploring PARP Inhibitor Combinations in Prostate Cancer
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.
This podcast is supported by an educational grant from Pfizer.
More on Biomarkers
Loading recent podcasts…
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 307
Jun 8, 2026
with Dr. Tanya Dorff, Dr. Evan Yu, Dr. Alan Tan
Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology,...
1,000+ listens
Tumor Board # 58
May 4, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Tumor Board # 54
Apr 6, 2026
with Dr. Tyler Stewart, Dr. Jun Gong
Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...
Tumor Board # 70
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du
How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored...
CardioNerds # 452
May 31, 2026
with Dr. Stavros Konstantinides, Dr. Billy Joe Mullinax, Dr. Dinu Balanescu, Dr. Jane Ehret
CardioNerds discuss risk stratification in acute pulmonary embolism with Dr. Stavros Konstantinides, Chair of the 2019...
Urology # 301
May 4, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
1,500+ listens
Urology # 287
Jan 29, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,500+ listens
Tumor Board Case
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.